XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Share-based Compensation, Stock Options, Activity
Stock option activity for the nine months ended October 31, 2023 was as follows:
 Options Outstanding
 Outstanding
Stock
Options
(in millions)
Weighted-
Average
Exercise Price
Aggregate
Intrinsic Value (in millions)
Balance as of January 31, 202323 $175.23 
Exercised(5)131.66 
Plan shares expired or canceled(2)204.09 
Balance as of October 31, 202316 $183.84 $480 
Vested or expected to vest16 $183.01 $474 
Exercisable as of October 31, 202311 $172.98 $407 
Schedule of Restricted Stock Activity
Restricted stock activity for the nine months ended October 31, 2023 was as follows:
 Restricted Stock Outstanding
 Outstanding
(in millions)
Weighted-Average Grant Date Fair ValueAggregate
Intrinsic
Value (in millions)
Balance as of January 31, 202329 $204.62 
Granted - restricted stock units and awards13 193.57 
Granted - performance-based stock units193.09 
Canceled(5)201.87 
Vested and converted to shares(10)203.80 
Balance as of October 31, 202328 $199.88 $5,807 
Expected to vest25 $4,974 
Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount
The aggregate expected stock-based compensation expense remaining to be recognized as of October 31, 2023 was as follows (in millions):
Fiscal Period:
Remaining three months of fiscal 2024$697 
Fiscal 20252,234 
Fiscal 20261,618 
Fiscal 2027796 
Fiscal 2028151 
Total stock-based compensation expense$5,496